Star Imaging & Path Lab Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 2,175,000 (44%) | — | ₹3,089 Cr |
| NII (HNI) | — | 657,000 (13%) | — | ₹933 Cr |
| Retail | — | 1,528,000 (31%) | — | ₹2,170 Cr |
| Market Maker | — | 480,000 (10%) | — | ₹68 Cr |
| Σ Total | — | 4,892,000 (100%) | — | ₹69,466 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹142,000 |
| Retail (Max) | 13 | 13,000 | ₹1,846,000 |
| S-HNI (Min) | 14 | 14,000 | ₹1,988,000 |
| B-HNI (Min) | 67 | 67,000 | ₹9,514,000 |
Financial Statements Amount in Crore
| Metric | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 84 | 80 | 59 |
| EBITDA | 29 | 22 | 6 |
| Profit After Tax | 16 | 12 | 1 |
| Net Worth | 47 | 31 | 19 |
| Total Assets | 98 | 82 | 61 |
| Reserves & Surplus | 34 | 30 | 17 |
| Total Borrowing | 33 | 31 | 27 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 To Meet Working Capital Requirement – 25.00
- 2 Repayment/prepayment of certain borrowings availed of by the Company – 12.00
- 3 Funding the Capital Expenditure towards purchase of Refurbished Medical Equipment in running facilities – 5.14
- 4 General corporate purposes – 6.94
Company Overview
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.
The company specializes in imaging services such as X-rays, ultrasounds, CT scans, MRIs, and laboratory tests, including blood tests, urine tests, and other specialized diagnostics.
With advanced technology and experienced medical professionals, the company aims to offer accurate and timely reports to patients, helping healthcare providers in effective diagnosis and treatment.
The company has a strong presence in multiple regions, offering services to both individuals and healthcare institutions.
Services:
- Radiology: Digital X-ray, Mammography, CT scans, 4D & 5D ultrasound services.
- Pathology: Haematology, Microbiology, PCR (polymerase chain reaction), Histopathology
- Diagnotics: Routine Testing, Special Testing
As of September 30th 2024, the company has 209 full time employees including executive directors.
Competitive Strengths:
- Accurate Diagnosis
- Specialized Expertise
- Proper Sample Collection and Processing Procedures